Company Quick10K Filing
Standex
10-Q 2021-03-31 Filed 2021-05-07
10-Q 2020-12-31 Filed 2021-02-05
10-Q 2020-09-30 Filed 2020-10-30
10-K 2020-06-30 Filed 2020-08-25
10-Q 2020-03-31 Filed 2020-05-08
10-Q 2019-12-31 Filed 2020-02-04
10-Q 2019-09-30 Filed 2019-11-06
10-K 2019-06-30 Filed 2019-08-27
10-Q 2019-04-29 Filed 2019-04-30
10-Q 2018-12-31 Filed 2019-01-31
10-Q 2018-09-30 Filed 2018-10-29
10-K 2018-06-30 Filed 2018-08-28
10-Q 2018-03-31 Filed 2018-05-01
10-Q 2017-12-31 Filed 2018-01-30
10-Q 2017-09-30 Filed 2017-11-01
10-K 2017-06-30 Filed 2017-08-28
10-Q 2017-03-31 Filed 2017-05-02
10-Q 2016-12-31 Filed 2017-02-03
10-Q 2016-09-30 Filed 2016-10-28
10-K 2016-06-30 Filed 2016-08-25
10-Q 2016-03-31 Filed 2016-05-03
10-Q 2015-12-31 Filed 2016-02-02
10-Q 2015-09-30 Filed 2015-10-29
10-K 2015-06-30 Filed 2015-08-27
10-Q 2015-03-31 Filed 2015-05-01
10-Q 2014-12-31 Filed 2015-02-03
10-Q 2014-09-30 Filed 2014-10-31
10-K 2014-06-30 Filed 2014-08-28
10-Q 2014-03-31 Filed 2014-05-02
10-Q 2013-09-30 Filed 2013-11-07
10-K 2013-06-30 Filed 2013-08-27
10-Q 2013-06-30 Filed 2014-02-03
10-Q 2013-03-31 Filed 2013-05-06
10-Q 2012-12-31 Filed 2013-02-01
10-Q 2012-09-30 Filed 2012-11-01
10-K 2012-06-30 Filed 2012-08-28
10-Q 2012-03-31 Filed 2012-05-02
10-Q 2011-12-31 Filed 2012-02-13
10-Q 2011-09-30 Filed 2011-10-27
10-K 2011-06-30 Filed 2011-09-08
10-Q 2011-03-31 Filed 2011-04-29
10-Q 2010-12-31 Filed 2011-01-28
10-Q 2010-09-30 Filed 2010-10-28
10-K 2010-06-30 Filed 2010-08-27
10-Q 2010-03-31 Filed 2010-04-29
10-Q 2009-12-31 Filed 2010-01-28
8-K 2020-10-29
8-K 2020-10-20
8-K 2020-08-26
8-K 2020-08-24
8-K 2020-07-15
8-K 2020-05-07
8-K 2020-04-01
8-K 2020-03-12
8-K 2020-02-03
8-K 2019-12-02
8-K 2019-10-22
8-K 2019-08-26
8-K 2019-08-23
8-K 2019-08-08
8-K 2019-04-01
8-K 2019-03-31
8-K 2019-01-30
8-K 2019-01-16
8-K 2018-12-21
8-K 2018-10-23
8-K 2018-10-05
8-K 2018-09-30
8-K 2018-09-28
8-K 2018-06-30
8-K 2018-05-01
8-K 2017-12-31

Standex Financials

SXI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2732323330514657748384969510411312212112188897510996110109118969390
Accounts Receivable929010390100102102101108102103110106929910410399114127135132133134124112116120114
Inventory7876919795859096971131151081131091091051061111191191231311321271121091038998
PP&E84849597972349499250110109253108109111245109111126277143145148301140142139306147
Assets4684555105075095115155415786516506606586606786906937118488688809179169171,0101,0141,003922949
Accounts Payable5351645756705966856869817157647763607496809383906356617367
Long-Term Debt64536662715050450126130010610910793105125216193206216205194300316293199190
Liabilities223198255241235220211212237304303312299294295320314332460459454496470466550561524458476
Stockholders' Equity245258255266273291304329341346346349359366382370379379388409426421446451460453480464473
Income Statement ($MM)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue155151183201166183184179197189181200198182177194180174185217214210217228193196194209196
Cost of Revenue105102124134113125124120119131124134130124119127118117123144140138143145124129132139128
Gross Profit5048596753585959645957656958596762576173747274826967627068
R&D
SG&A3537414340394143384239414441414542404348505152544546454849
Tax43561544644773526231052010464455
Net Income-49121410129131011131616121212141081514413131613261212
Cash Flow ($MM)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating141015-74411636114382316341191033-53133616488
Cash Investing12-43-6-3-0-4-4-20-5-4-5-17-5-4-6-31-134-8-17-6-4-102-3592
Cash Financing-2112-88-22-3-2-31-2802-5-1851789-2688-14-14103-25-111-11